These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23725092)

  • 41. Implementing guidelines to routinely prevent chronic vascular disease in primary care: the Preventive Evidence into Practice cluster randomised controlled trial.
    Harris MF; Parker SM; Litt J; van Driel M; Russell G; Mazza D; Jayasinghe UW; Del Mar C; Lloyd J; Smith J; Zwar N; Taylor R; Powell Davies G;
    BMJ Open; 2015 Dec; 5(12):e009397. PubMed ID: 26656984
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 43. General health checks in adults for reducing morbidity and mortality from disease.
    Krogsbøll LT; Jørgensen KJ; Grønhøj Larsen C; Gøtzsche PC
    Cochrane Database Syst Rev; 2012 Oct; 10():CD009009. PubMed ID: 23076952
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lifestyle and risk factor management in people at high risk of cardiovascular disease. A report from the European Society of Cardiology European Action on Secondary and Primary Prevention by Intervention to Reduce Events (EUROASPIRE) IV cross-sectional survey in 14 European regions.
    Kotseva K; De Bacquer D; De Backer G; Rydén L; Jennings C; Gyberg V; Abreu A; Aguiar C; Conde AC; Davletov K; Dilic M; Dolzhenko M; Gaita D; Georgiev B; Gotcheva N; Lalic N; Laucevicius A; Lovic D; Mancas S; Miličić D; Oganov R; Pajak A; Pogosova N; Reiner Ž; Vulic D; Wood D; On Behalf Of The Euroaspire Investigators
    Eur J Prev Cardiol; 2016 Dec; 23(18):2007-2018. PubMed ID: 27638542
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An evaluation of the DEXLIFE 'self-selected' lifestyle intervention aimed at improving insulin sensitivity in people at risk of developing type 2 diabetes: study protocol for a randomised controlled trial.
    O'Donoghue GM; Kennedy A; Andersen GS; Durkan E; Thybo T; Sinnott M; Nolan JJ; O'Gorman DJ
    Trials; 2015 Nov; 16():529. PubMed ID: 26581687
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assessment and management of lifestyle risk factors in rural and urban general practices in Australia.
    Passey M; Fanaian M; Lyle D; Harris MF
    Aust J Prim Health; 2010; 16(1):81-6. PubMed ID: 21133303
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness of a prevention program in the incidence of cardiovascular outcomes in a low-income population from Colombia: a real-world propensity score-matched cohort study.
    Miranda-Machado P; Salcedo-Mejía F; Parra-Padilla D; Vargas-Moranth R; Alvis-Zakzuk NR; Paz-Wilches J; Fernández-Mercado J; De la-Hoz Restrepo F; Alvis-Guzmán N
    BMC Public Health; 2020 Sep; 20(1):1416. PubMed ID: 32943016
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exercise Evaluation Randomised Trial (EXERT): a randomised trial comparing GP referral for leisure centre-based exercise, community-based walking and advice only.
    Isaacs AJ; Critchley JA; Tai SS; Buckingham K; Westley D; Harridge SD; Smith C; Gottlieb JM
    Health Technol Assess; 2007 Mar; 11(10):1-165, iii-iv. PubMed ID: 17313906
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A 3-year randomized trial of lifestyle intervention for cardiovascular risk reduction in the primary care setting: the Swedish Björknäs study.
    Eriksson MK; Franks PW; Eliasson M
    PLoS One; 2009; 4(4):e5195. PubMed ID: 19365563
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of 5-year community intervention Hartslag Limburg on cardiovascular risk factors.
    Schuit AJ; Wendel-Vos GC; Verschuren WM; Ronckers ET; Ament A; Van Assema P; Van Ree J; Ruland EC
    Am J Prev Med; 2006 Mar; 30(3):237-42. PubMed ID: 16476640
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevention of diabetes and cardiovascular diseases in occupational health care: feasibility and effectiveness.
    Viitasalo K; Hemiö K; Puttonen S; Hyvärinen HK; Leiviskä J; Härmä M; Peltonen M; Lindström J
    Prim Care Diabetes; 2015 Apr; 9(2):96-104. PubMed ID: 25128324
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A tailored lifestyle intervention to reduce the cardiovascular disease risk of individuals with Familial Hypercholesterolemia (FH): design of the PRO-FIT randomised controlled trial.
    Broekhuizen K; van Poppel MN; Koppes LL; Brug J; van Mechelen W
    BMC Public Health; 2010 Feb; 10():69. PubMed ID: 20156339
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-effectiveness of a cardiovascular disease primary prevention programme in a primary health care setting. Results of the Polish part of the EUROACTION project.
    Sović N; Pająk A; Jankowski P; Duenas A; Kawecka-Jaszcz K; Wolfshaut-Wolak R; Stepaniak U; Kawalec P
    Kardiol Pol; 2013; 71(7):702-11. PubMed ID: 23907903
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical and cost-effectiveness of an intervention for reducing cholesterol and cardiovascular risk for people with severe mental illness in English primary care: a cluster randomised controlled trial.
    Osborn D; Burton A; Hunter R; Marston L; Atkins L; Barnes T; Blackburn R; Craig T; Gilbert H; Heinkel S; Holt R; King M; Michie S; Morris R; Morris S; Nazareth I; Omar R; Petersen I; Peveler R; Pinfold V; Walters K
    Lancet Psychiatry; 2018 Feb; 5(2):145-154. PubMed ID: 29396118
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cardiovascular risk factors among high-risk individuals attending the general practice at king Abdulaziz University hospital: a cross-sectional study.
    Ghamri RA; Alzahrani NS; Alharthi AM; Gadah HJ; Badoghaish BG; Alzahrani AA
    BMC Cardiovasc Disord; 2019 Nov; 19(1):268. PubMed ID: 31775642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Outcomes of national community organization cardiovascular prevention programs for high-risk women.
    Villablanca AC; Arline S; Lewis J; Raju S; Sanders S; Carrow S
    J Cardiovasc Transl Res; 2009 Sep; 2(3):306-20. PubMed ID: 19654887
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multiple Risk Factor Interventions for Primary Prevention of CVD in LMIC: A Cochrane Review.
    Uthman OA; Hartley L; Rees K; Taylor F; Ebrahim S; Clarke A
    Glob Heart; 2017 Sep; 12(3):199-208.e8. PubMed ID: 27452771
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The impact of a disease management program (COACH) on the attainment of better cardiovascular risk control in dyslipidaemic patients at primary care centres (The DISSEMINATE Study): a randomised controlled trial.
    Selvaraj FJ; Mohamed M; Omar K; Nanthan S; Kusiar Z; Subramaniam SY; Ali N; Karanakaran K; Ahmad F; Low WH;
    BMC Fam Pract; 2012 Oct; 13():97. PubMed ID: 23046818
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of training community health workers and their interventions on cardiovascular disease risk factors among adults in Morogoro, Tanzania: study protocol for a cluster randomized controlled trial.
    Muhihi AJ; Urassa DP; Mpembeni RNM; Leyna GH; Sunguya BF; Kakoko D; Kessy AT; Njelekela MA
    Trials; 2018 Oct; 19(1):552. PubMed ID: 30314511
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.